1. Home
  2. UPC vs LGVN Comparison

UPC vs LGVN Comparison

Compare UPC & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Universe Pharmaceuticals Inc.

UPC

Universe Pharmaceuticals Inc.

HOLD

Current Price

$1.06

Market Cap

7.0M

Sector

Health Care

ML Signal

HOLD

Logo Longeveron Inc.

LGVN

Longeveron Inc.

SELL

Current Price

$1.79

Market Cap

7.8M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
UPC
LGVN
Founded
1998
2014
Country
China
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medicinal Chemicals and Botanical Products
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.0M
7.8M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
UPC
LGVN
Price
$1.06
$1.79
Analyst Decision
Analyst Count
0
0
Target Price
N/A
★ $61.25
AVG Volume (30 Days)
★ 161.9K
84.9K
Earning Date
01-29-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 50.76
EPS
★ N/A
N/A
Revenue
N/A
★ $709,000.00
Revenue This Year
N/A
$46.15
Revenue Next Year
N/A
$24.63
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$1.33
$0.48
52 Week High
$17.96
$7.60

Technical Indicators

Market Signals
Indicator
UPC
LGVN
Relative Strength Index (RSI) 23.99 41.72
Support Level N/A $0.65
Resistance Level $1.68 $1.86
Average True Range (ATR) 0.17 0.29
MACD 0.06 -0.01
Stochastic Oscillator 19.84 4.21

Price Performance

Historical Comparison
UPC
LGVN

About UPC Universe Pharmaceuticals Inc.

Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.

About LGVN Longeveron Inc.

Longeveron Inc is a clinical stage biotechnology company developing regenerative medicines to address unmet medical needs. Its investigational product candidate is laromestrocel. Laromestrocel is a proprietary, scalable, allogeneic cellular therapy that has multiple potential modes of action that include pro-vascular, pro-regenerative, and anti-inflammatory mechanisms that collectively appear to promote tissue repair and healing. It is in clinical development of a single investigational product candidate, laromestrocel, for four potential indications: HLHS, Alzheimer's disease (AD), Pediatric Dilated Cardiomyopathy (pediatric DCM), and Aging-related Frailty. It operates in a single operating segment focused on developing regenerative medicines to address unmet medical needs.

Share on Social Networks: